Plus Therapeutics Inc is a biotechnology company focused on developing innovative therapies for cancer treatment

The company utilizes a proprietary nanoscale particle technology aimed at delivering targeted, localized therapies to improve patient outcomes while minimizing systemic side effects. Their pipeline includes treatments designed to address various types of cancer, with a particular emphasis on rare and hard-to-treat indications. Through its research and development efforts, Plus Therapeutics is committed to advancing the science of cancer care and providing new options for patients facing challenging diagnoses.